SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-005176
Filing Date
2020-01-17
Accepted
2020-01-17 17:06:57
Documents
13
Period of Report
2020-01-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm202186d4_8k.htm   iXBRL 8-K 33572
2 EXHIBIT 2.1 tm202186d4_ex2-1.htm EX-2.1 33516
  Complete submission text file 0001104659-20-005176.txt   248620

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA elan-20200116.xsd EX-101.SCH 3180
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE elan-20200116_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elan-20200116_pre.xml EX-101.PRE 22706
8 EXTRACTED XBRL INSTANCE DOCUMENT tm202186d4_8k_htm.xml XML 3491
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

IRS No.: 825497352 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38661 | Film No.: 20534291
SIC: 2834 Pharmaceutical Preparations